Icahn Falls Slightly In Q1

May 15 2014 | 2:46pm ET

Carl Icahn is going to need an impressive run the rest of the year if he’s to keep up his recent torrid pace.

Icahn Enterprises lost 0.4% in the first quarter, Forbes reports. Much of the decline can be attributed to Icahn’s big bet on nutritional supplements company Herbalife, whose stock has plummeted this year amidst a number of state and federal investigations.

Icahn is still up significantly on the Herbalife investment.

The loss was offset by a big win for Icahn’s second-biggest investment at the start of the year, Forest Laboratories, which in February was acquired for $25 billion.

Icahn has returned an annualized 27% over the past five years, including a 30.8% rise last year.


In Depth

Steinbrugge: Top 10 Hedge Fund Industry Trends for 2017

Jan 3 2017 | 9:03pm ET

Each year, Agecroft Partners' Don Steinbrugge predicts the top hedge fund industry...

Lifestyle

'Tis the Season: Wall Street Holiday Parties Back In Fashion

Dec 22 2016 | 9:23pm ET

Spending on Wall Street holiday parties has largely returned to pre-2008 levels...

Guest Contributor

DarcMatter: The Top Trends in Alternative Investments for 2017

Jan 13 2017 | 8:22pm ET

The $7 trillion alternative investments industry is poised for continued growth...

 

From the current issue of

The U.S. Commodity Futures Trading Commission (CFTC) ordered The Goldman Sachs Group Inc., and Goldman, Sachs & Co. to pay a $120 million penalty for attempted manipulation and false reporting of ISDAFIX Benchmark Rates, a global benchmark for interest rate products.